Emkay Taps & Cutting Tools Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 11:20 am

Quick Insight

Emkay Taps & Cutting Tools Ltd, with a current share price of ₹210 and a market capitalization of ₹224 crore, presents an intriguing investment opportunity, especially given its low price-to-earnings (P/E) ratio of 8.34. The company boasts a robust return on equity (ROE) of 9.14% and return on capital employed (ROCE) of 10.4%, indicating efficient management of shareholder funds. Additionally, an operating profit margin (OPM) of 46% underlines its operational efficiency. With a comfortable interest coverage ratio (ICR) of 412.78x and minimal borrowings of ₹4 crore against reserves of ₹277 crore, Emkay exhibits financial stability. The promoter holding at 74.99% reinforces confidence in its governance. Given these metrics, investors may find Emkay Taps a compelling candidate for value investing, particularly in the engineering sector.

Competitors of Emkay Taps & Cutting Tools Ltd

All Competitor Stocks of Emkay Taps & Cutting Tools Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:45 pm

Below is a detailed analysis of the quarterly data for Emkay Taps & Cutting Tools Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Sep 2024) to 41.00 Cr., marking a decrease of 14.00 Cr..
• For Expenses, as of Mar 2025, the value is 43.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.00 Cr. (Sep 2024) to 43.00 Cr., marking an increase of 13.00 Cr..
• For Operating Profit, as of Mar 2025, the value is -1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Sep 2024) to -1.00 Cr., marking a decrease of 26.00 Cr..
• For OPM %, as of Mar 2025, the value is -4.00%. The value appears to be declining and may need further review. It has decreased from 46.00% (Sep 2024) to -4.00%, marking a decrease of 50.00%.
• For Other Income, as of Mar 2025, the value is -8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Sep 2024) to -8.00 Cr., marking a decrease of 51.00 Cr..
• For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
• For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.00 Cr. (Sep 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is -9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Sep 2024) to -9.00 Cr., marking a decrease of 76.00 Cr..
• For Tax %, as of Mar 2025, the value is -11.00%. The value appears to be improving (decreasing) as expected. It has decreased from 18.00% (Sep 2024) to -11.00%, marking a decrease of 29.00%.
• For Net Profit, as of Mar 2025, the value is -8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Sep 2024) to -8.00 Cr., marking a decrease of 63.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is -7.70. The value appears to be declining and may need further review. It has decreased from 51.40 (Sep 2024) to -7.70, marking a decrease of 59.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:38 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:11 pm

Below is a detailed analysis of the balance sheet data for Emkay Taps & Cutting Tools Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 277.00 Cr.. The value appears to be declining and may need further review. It has decreased from 288.00 Cr. (Mar 2024) to 277.00 Cr., marking a decrease of 11.00 Cr..
• For Borrowings, as of Mar 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 6.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 2.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing). It has decreased from 32.00 Cr. (Mar 2024) to 7.00 Cr., marking a decrease of 25.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 299.00 Cr.. The value appears to be improving (decreasing). It has decreased from 337.00 Cr. (Mar 2024) to 299.00 Cr., marking a decrease of 38.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 12.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 283.00 Cr.. The value appears strong and on an upward trend. It has increased from 255.00 Cr. (Mar 2024) to 283.00 Cr., marking an increase of 28.00 Cr..
• For Other Assets, as of Mar 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Mar 2024) to 14.00 Cr., marking a decrease of 55.00 Cr..
• For Total Assets, as of Mar 2025, the value is 299.00 Cr.. The value appears to be declining and may need further review. It has decreased from 337.00 Cr. (Mar 2024) to 299.00 Cr., marking a decrease of 38.00 Cr..

Notably, the Reserves (277.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Emkay Taps & Cutting Tools Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 67.38. This value is within the healthy range. It has increased from 41.35 (Mar 23) to 67.38, marking an increase of 26.03.
• For Diluted EPS (Rs.), as of Mar 24, the value is 67.38. This value is within the healthy range. It has increased from 41.35 (Mar 23) to 67.38, marking an increase of 26.03.
• For Cash EPS (Rs.), as of Mar 24, the value is 69.82. This value is within the healthy range. It has increased from 44.27 (Mar 23) to 69.82, marking an increase of 25.55.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 280.10. It has increased from 211.71 (Mar 23) to 280.10, marking an increase of 68.39.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 280.10. It has increased from 211.71 (Mar 23) to 280.10, marking an increase of 68.39.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 96.94. It has increased from 83.04 (Mar 23) to 96.94, marking an increase of 13.90.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 87.07. This value is within the healthy range. It has increased from 56.11 (Mar 23) to 87.07, marking an increase of 30.96.
• For PBIT / Share (Rs.), as of Mar 24, the value is 84.62. This value is within the healthy range. It has increased from 53.19 (Mar 23) to 84.62, marking an increase of 31.43.
• For PBT / Share (Rs.), as of Mar 24, the value is 84.41. This value is within the healthy range. It has increased from 53.06 (Mar 23) to 84.41, marking an increase of 31.35.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 67.38. This value is within the healthy range. It has increased from 41.35 (Mar 23) to 67.38, marking an increase of 26.03.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 67.38. This value is within the healthy range. It has increased from 41.35 (Mar 23) to 67.38, marking an increase of 26.03.
• For PBDIT Margin (%), as of Mar 24, the value is 89.81. This value is within the healthy range. It has increased from 67.56 (Mar 23) to 89.81, marking an increase of 22.25.
• For PBIT Margin (%), as of Mar 24, the value is 87.29. This value exceeds the healthy maximum of 20. It has increased from 64.05 (Mar 23) to 87.29, marking an increase of 23.24.
• For PBT Margin (%), as of Mar 24, the value is 87.07. This value is within the healthy range. It has increased from 63.89 (Mar 23) to 87.07, marking an increase of 23.18.
• For Net Profit Margin (%), as of Mar 24, the value is 69.50. This value exceeds the healthy maximum of 10. It has increased from 49.79 (Mar 23) to 69.50, marking an increase of 19.71.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 69.50. This value exceeds the healthy maximum of 20. It has increased from 49.79 (Mar 23) to 69.50, marking an increase of 19.71.
• For Return on Networth / Equity (%), as of Mar 24, the value is 24.05. This value is within the healthy range. It has increased from 19.53 (Mar 23) to 24.05, marking an increase of 4.52.
• For Return on Capital Employeed (%), as of Mar 24, the value is 30.15. This value is within the healthy range. It has increased from 25.01 (Mar 23) to 30.15, marking an increase of 5.14.
• For Return On Assets (%), as of Mar 24, the value is 21.30. This value is within the healthy range. It has increased from 17.18 (Mar 23) to 21.30, marking an increase of 4.12.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.02. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.02.
• For Current Ratio (X), as of Mar 24, the value is 1.80. This value is within the healthy range. It has increased from 1.76 (Mar 23) to 1.80, marking an increase of 0.04.
• For Quick Ratio (X), as of Mar 24, the value is 1.37. This value is within the healthy range. It has increased from 1.19 (Mar 23) to 1.37, marking an increase of 0.18.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 412.78. This value is within the healthy range. It has decreased from 419.60 (Mar 23) to 412.78, marking a decrease of 6.82.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 320.41. This value is within the healthy range. It has increased from 310.23 (Mar 23) to 320.41, marking an increase of 10.18.
• For Enterprise Value (Cr.), as of Mar 24, the value is 696.36. It has increased from 318.17 (Mar 23) to 696.36, marking an increase of 378.19.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 6.73. This value exceeds the healthy maximum of 3. It has increased from 3.59 (Mar 23) to 6.73, marking an increase of 3.14.
• For EV / EBITDA (X), as of Mar 24, the value is 7.49. This value is within the healthy range. It has increased from 5.31 (Mar 23) to 7.49, marking an increase of 2.18.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 6.70. This value exceeds the healthy maximum of 3. It has increased from 3.54 (Mar 23) to 6.70, marking an increase of 3.16.
• For Price / BV (X), as of Mar 24, the value is 2.32. This value is within the healthy range. It has increased from 1.39 (Mar 23) to 2.32, marking an increase of 0.93.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 6.70. This value exceeds the healthy maximum of 3. It has increased from 3.54 (Mar 23) to 6.70, marking an increase of 3.16.
• For EarningsYield, as of Mar 24, the value is 0.10. This value is below the healthy minimum of 5. It has decreased from 0.14 (Mar 23) to 0.10, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness